articleEuropean Journal of Clinical PharmacologyNov 17, 2005Closed access

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects

DKDagmar KubitzaMBMichael BeckaGWGeorg WensingBVBarbara VoithMZMichael Zuehlsdorf

Bayer (Germany)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

648
total citations
FWCI
10.66
Percentile
100%
References
16
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Pharmacokinetics
  • Pharmacodynamics
  • Tolerability
  • Medicine
  • Dosing
  • Pharmacology
  • Partial thromboplastin time
  • Placebo
No related works found for this paper.